ÂÜÀòÂÒÂ×

Narin Ahmed has extensive experience in regulatory affairs and leadership roles in the pharmaceutical industry. They have held positions at various companies including Tessera Therapeutics, GentiBio, Bristol Myers Squibb, and Novartis. Narin's roles have included Vice President, Regulatory Science at Tessera Therapeutics and Vice President and Head of Regulatory Affairs at GentiBio. They have also served as a Senior Director and Global Regulatory Lead at Bristol Myers Squibb, and as a Global Program Regulatory Director and Associate Director at Novartis. Prior to their industry experience, Narin worked as an Adjunct Faculty member at Rutgers University, where they taught leadership and professionalism courses for pharmacy professionals.

Narin Ahmed attended the University of Ottawa from 2002 to 2006 and earned a Bachelor of Science degree in Biopharmaceutical Science and Genomics. Narin then attended Temple University from 2006 to 2010 and obtained a PharmD degree. From 2010 to 2012, Narin Ahmed pursued a PharmD Fellowship at Rutgers University.